In the U.S., Hispanic/Latino people have been disproportionately affected by HIV since the epidemic’s beginning, and that disparity has deepened over time. Hispanic/Latino people represent a larger share of HIV diagnoses and people estimated to be living with HIV relative to their population size. This fact sheet provides an overview of the impact of HIV…
This brief provides an overview of the role of PBMs in managing pharmacy benefits, discusses recent federal legislation focusing on several elements of PBM business practices, and explains the potential federal budgetary impact of this legislation, which would have a relatively modest impact on the federal deficit, based on available CBO estimates.
Society of General Internal Medicine and North American Primary Care Research Group say HHS has destroyed AHRQ’s capacity to process grant applications
Novavax’s partnership with Sanofi allows the pharma giant to explore potential combinations of assets from both companies, and it’s a blueprint for the kinds of alliances the vaccine developer is pursuing. Rather than commercializing vaccines, Novavax aims to turn its research into business development deals, R&D executive Ruxandra Draghia-Akli said. The post Novavax Sees Sanofi…
The U.S. government is the largest donor to global health in the world. This fact sheet breaks down the U.S. global health budget by program area: HIV/PEPFAR; tuberculosis; malaria/the President’s Malaria Initiative; the Global Fund to Fight AIDS, Tuberculosis, and Malaria; maternal & child health; nutrition; family planning & reproductive health; global health security; and…
For two decades, Washington, D.C., pediatrician Lanre Falusi has counseled parents about vaccine safety, side effects, and timing. But this year, she said, the conversations have changed. “For the first time, I’m having parents of newborns ask me if their baby will still be able to get vaccines,” Falusi said. Throughout the country, pediatricians say…
With the expiration of ACA subsidies and a decline in enrollment, lawmakers face uncertainty
The way we measure ALS progression is failing patients. We are entering a new era of ALS therapeutics but still relying on the same blunt instruments of measurement. The post In the Absence of Objective Measures for ALS, Caregivers are the Only Witnesses. We Shouldn’t Have To Be. appeared first on MedCity News.
When Matthew Hurley was looking to take PrEP to prevent HIV, the doctor hadn’t heard of the medicine, and when he finally did prescribe PrEP, the bills sent to Hurley were expensive … and wrong. “I decided to write in because the process was really super frustrating.” At one point, Hurley asked, “Am I just…
This Monitor highlights April KFF Tracking Poll findings on perceptions about measles and explores the unsubstantiated promotion of budesonide and clarithromycin as treatments. It also covers misrepresentations of syringe programs and how prompting strategies can boost the accuracy of AI chatbots on health questions.